The association between Barrett's esophagus and Helicobacter pylori infection: A meta-analysis

Helicobacter

Volumn 17, Issue 3, 2012, Pages 163-175

  Fischbach, Lori A ^a   Nordenstedt, Helena ^b,c   Kramer, Jennifer R ^b,c   Gandhi, Subi ^a   Dick Onuoha, Sam ^a   Lewis, Anthony ^a   El Serag, Hashem B ^b,c  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Helicobacter pylori; Meta analysis

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; ENDOSCOPY; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; GEOGRAPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SEROLOGY; STOMACH PROTECTION;

BARRETT ESOPHAGUS; ESOPHAGEAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84860204739     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00931.x     Document Type: Article

References (80)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
3. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesphagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2007;57:1354-9.
4. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-31.
5. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrettt's) esophagus comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
6. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009;373:850-61.
7. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
8. Cook MB, Wild CP, Everett SM, et al. Risk of mortality and cancer incidence in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2095-6.
9. Correa P. The epidemiology of gastric cancer. World J Surg 1991;15:228-34.
10. Correa P. The human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60. [].
11. Fischbach LA, Correa P, Feldman M, Fontham E, Priest EL, Goodman KJ, Jain R. Increased reflux symptoms after calcium carbonate supplementation and successful Helicobacter pylori treatment: results from a randomized clinical trial in a population with a high prevalence of multifocal atrophic gastritis. Dig Dis Sci 2003;48:1487-94.
12. Henihan RD, Stuart RC, Nolan N, et al. Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 1998;93:542-6.
13. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992;87:1598-600.
14. Meng X, Scheer MA, Tsang TK. GERD, Barrett's esophagus and Helicobacter pylori infection. Gastroenterology 2008;134:A443.
15. Csendes A, Smok G, Cerda G, Burdiles P, Mazza D, Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus 1997;10:38-42.
16. Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009;41:1011-7.
17. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Rumore G, Qusenberry C, Buffler P, Block G. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008;57:727-33.
18. Fassan M, Rugge M, Parente P, Tieppo C, Rugge M, Battaglia G. The role of Helicobacter pylori in the spectrum of Barrett's carcinogenesis. Cancer Prev Res 2009;2:94.
19. Sonnenberg A, Lash R, Genta R. A national study of Helicobacter pylori infection in gastric biopsy specimens. Gastroenterology 2010;139:1894-901.
20. Rokkas T, Pistiolas D, Sechopoulous P, et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007;5:1413-7.
21. Gisbert JP, Pajares JM. Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barrett's esophagus. Med Clin (Barc) 2002;119:217-23.
22. Wang C, Yuan Y, Hunt RH. Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol 2009;104:494-500.
23. Abbas Z, Hussainy AS, Ibrahim F, Jafri S, Shaikh H, Khan AH. Barrett's oesophagus and Helicobacter pylori. J Gastroenterol Hepatol 1995;10:331-3.
24. Abouda GF, Cotton JC, Dillon JF. Prevalence of Helicobacter pylori virulence factors in patients with reflux oesophagitis and Barrett's oesophagus. Gut 2003;52:A411.
25. Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734-9.
26. Blaser MJ, Perez-Perez GL, Lindenbaum J, et al. Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis 1991;13(Suppl 8):S704-8.
27. Chacaltana A, Urday C, Ramon W, Rodríguez C, Espinoza J, Velarde H. [Prevalence, clinical-endoscopic characteristics and predictive factors of Barrett's esophagus in endoscopic screening for gastric cancer]. Rev Gastroenterol Peru 2009;29:24-32.
28. El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999;94:622-7.
29. Ferrández A, Benito R, Arenas J, García-González MA, Sopeña F, Alcedo J. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 2006;6:7.
30. Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2006;97:302-11.
31. Hackelsberger A, Günther T, Schultze V, Manes G, Dominguez-Muñoz JE, Roessner A. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21.
32. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplsia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
33. Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol 2006;101:926-33.
34. Johansson J, Håkansson HO, Mellblom L, Kempas A, Johansson KE, Granath F. Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol 2007;42:148-56.
35. Jonaitis L, Kriukas D, Sakalauskas L, Janciauskas D, Kupcinskas L. Prevalence of H-pylori among patients with erosive esophagitis and Barrett's esophagus among routinely endoscoped patients in high H-pylori prevalence area. Helicobacter 2008;13:440-1.
36. Kala Z, Dolina J, Marek F, Izakovicova Holla L. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus. J Hum Genet 2007;52:527-34.
37. Kiltz U, Baier J, Schmidt WE, Adamek RJ. Barrett's metaplasia and Helicobacter pylori infection (letter). Am J Gastroenterol 1999;94:1985-6.
38. Laheij RJ, Van Rossum LG, De Boer WA, Jansen JB. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus. Aliment Pharmacol Ther 2002;16:887-91.
39. Lam KD, Phan JT, Garcia RT, Trinh H, Nguyen H, Nguyen K. Low proportion of Barrett's esophagus in Asian Americans. Am J Gastroenterol 2008;103:1625-30.
40. Loffeld RJ, Werdmuller BF, Kuster JG, Pérez-Pérez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000;62:95-9.
41. Loffeld RJ, van der Putten AB. Helicobacter pylori and gastro-oesophageal reflux disease: a cross-sectional epidemiological study. Neth J Med 2004;62:188-91.
42. Lord RV, Frommer DJ, Inder S, Tran D, Ward RL. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust N Z J Surg 2000;70:26-33.
43. Martinek J, Hucl T, Spicak J. The prevalence of Helicobacter pylori infection in some disease of the esophagus, stomach and duodenum - a retrospective analysis. Ces a slov Gastroerit a Hepatol 2003;57:228-32.
44. Monkemuller K, Neumann H, Nocon M, et al. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther 2008;28:491-6.
45. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-5.
46. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997;40:9-13.
47. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagi. Gastroenterology 1988;95:216-8.
48. Peng S, Xiong LS, Xiao YL, et al. Prompt upper endoscopy is an appropriate initial management in uninvestigated patients with typical reflux symptoms. Am J Gastroenterol 2010;105:1947-52.
49. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty KM. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter 2007;12:177-83.
50. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci 2004;49:237-42.
51. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
52. Rugge M, Russo V, Busatto G, et al. The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol 2001;54:456-60.
53. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999;94:884-7.
54. Sirigu F, Capeccioni S, Dessì A, Masia AM. Helicobacter pylori in Barrett's esophagus and in normal or inflamed esophageal mucosa: a retrospective study. Riv Eur Sci Med Farmacol 1994;16:131-4.
55. Toruner M, Soyikan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 2004;19:535-40.
56. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
57. Vieth M, Masoud B, Meining A, Stolte M. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion 2000;62:225-31.
58. Watari J, Morichi K, Tanabe H, et al. Differences in genetic instability and cellular phenotype among Barrett's, cardiac and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori. Histopathology 2009;55:261-9.
59. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in pathogenesis of reflux esophagitis. Dig Dis Sci 1997;42:103-5.
60. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000;95:387-94.
61. White NM, Gabril M, Ejeckam G, et al. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum. Can J Gastroenterol 2008;22:369-75.
62. Zaninotto G, Portale G, Parenti A, Lanza C, Costantini M, Molena D. Role of acid and bile reflux in development of specialized intestinal metaplasia in distal oesophagus. Dig Liver Dis 2002;34:251-7.
63. Kuper H, Nicholson A, Hemingway H. Searching for observational studies: what does citation tracking add to PubMed? A case study in depression and coronary heart disease. BMC Med Res Methodol 2006;6:4.
64. Greenland S. Meta-analysis. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers, 1998;643-73.
65. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.
66. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 1994;140:290-6.
67. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2001;2:463-71.
68. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
69. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000;95:2206-11.
70. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of The American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
71. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen EM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999;45:181-5.
72. Goodman KJ, Correa P, Tengana Aux HJ, DeLany JP, Collazos T. Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr 1997;25:507-15.
73. Moujaber T, MacIntryre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 2008;12:500-4.
74. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007;12(Suppl 1):1-3.
75. Flood VM, Burlutsky G, Webb KL, Wang JJ, Smith WT, Mitchell P. Food and nutrient consumption trends in older Australians: a 10-year cohort study. Eur J Clin Nutr 2010;64:603-13.
76. Chang UJ, Hong YH, Suh HJ, Jund EY. Lowering the energy density of parboiled rice by adding water rich vegetables can decrease total energy intake in a parboiled rice-based diet without reducing satiety on healthy women. Appetite 2010;55:338-42.
77. Jacobson BC, Chan AT, Giovannucci El, et al. Body mass index and Barrett's oesophagus in women. Gut 2009;58:1460-6.
78. Abrams JA. Obesity and Barrett's oesophagus: more than just reflux. Gut 2009;58:1437-8.
79. Sugerman HJ. Increased intra-abdominal pressure and GERD/Barrett's esophagus. Gastroenterology 2007;133:2075.
80. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007;133:34-41.